BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
278 hedge funds and large institutions have $3.94B invested in bluebird bio in 2020 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 119 increasing their positions, 52 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
278
Holders Change
+31
Holders Change %
+12.55%
% of All Funds
5.71%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
71
Increased
119
Reduced
52
Closed
39
Calls
$39.6M
Puts
$46.1M
Net Calls
-$6.51M
Net Calls Change
+$4.37M
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136M |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$90.8M |
3 |
Capital Research Global Investors
Los Angeles,
California
|
+$78.3M |
4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$77.8M |
5 |
BlackRock
New York
|
+$67.8M |